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Binding of recombinant IK17 to vascular lipid deposits in 
HCD-fed larvae. (A) Binding of fluorescently labeled IK17-
Alexa488 and TT-Alexa488 to MDA-LDL and OxLDL was 
tested in a microplate immunoassay with anti-HA antibody 
detection, as described in Methods. Two independent 
experiments were performed in quadruplicates. nLDL, 
native LDL. (B) Zebrafish larvae were fed a HCD or con-
trol diet supplemented with 10 μg/g cholesteryl BODIPY 
576/589 C11 for 14 days. At the end of the feeding period, 
larvae were injected into the caudal vein with 2 nl 10 ng/μl 
IK17-Alexa488 or TT-Alexa488. Twenty-four hours after 
injection, larvae were anesthetized and imaged live under 
a confocal microscope. Lipid deposits (bright red) and sites 
of IK17-Alexa488 binding (green) partially colocalize (yel-
low) in the wall of the caudal vein. Diffuse red fluorescence 
in the lumen is from circulating lipid marker associated with 
plasma lipoproteins; its intensity varies depending on the 
cholesterol content in diet. DA, dorsal aorta; CV, caudal 
vein. Scale bar: 25 μm. Representative images from 4 ani-
mals in each group.
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Transgenic hsp70:IK17-EGFP and hsp70:TT-EGFP zebrafish. (A) HEK293 cells were transiently transfected with EGFP or IK17-EGFP, and 48 
hours after transfection, the supernatants were analyzed for binding with MDA-LDL and OxLDL in a microplate assay with an anti-GFP detection 
antibody. Two independent experiments were performed in quadruplicates. (B) Diagram showing the hsp70:IK17-EGFP and hsp70:TT-EGFP 
constructs used to generate transgenic lines. Tol2, a transposable DNA element; ss, secretion signal; pA, polyA sequence. (C) Founder hsp70:
IK17-EGFP and hsp70:TT-EGFP zebrafish were genotyped with IK17 and TT primers. The hairline splices denote lanes that were run on the same 
gel but were noncontiguous. NC, negative control; PC, positive control. (D) Two dpf F1 larvae of hsp70:IK17-EGFP and hsp70:TT-EGFP zebrafish 
were subjected to heat shock (HS). EGFP fluorescence was accessed 24 hours after heat shock. NHS, the larvae that were not subjected to heat 
shock. Dotted lines trace contours of the larvae that were not subjected to heat shock. Scale bar: 100 μm. (E) One group of 3 dpf hsp70:IK17-
EGFP and hsp70:TT-EGFP larvae was subjected to heat shock, while the other group was not subjected to heat shock. Two days later, 30 fish from 
each group were homogenized; the homogenates were cleared by centrifugation and filtration, diluted 1:50, and tested for binding to MDA-LDL 
and OxLDL in a microplate assay with an anti-GFP detection antibody. Two independent experiments were performed in quadruplicates.
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IK17-EGFP fusion expressed in zebrafish is as efficient an anti-
body as the parent IK17 Fab in recognizing the MDA epitope.























IK17-EGFP binding to vascular lipid deposits in HCD-fed transgenic larvae — time course and effect of dietary intervention. (A) hsp70:IK17-
EGFP and hsp70:TT-EGFP zebrafish larvae were fed a HCD for 3 days, followed by heat shock (1 hour at 37°C) and 2 more days of feeding 
with a HCD supplemented with cholesteryl BODIPY 576/589. Control groups were fed either control diet and subjected to heat shock or fed HCD 
but not subjected to heat shock. Colocalization of green EGFP and red lipid marker signals was observed only in HCD-fed hsp70:IK17-EGFP 
subjected to heat shock (arrows). Dashed lines trace the caudal vein in GFP-only images. Scale bar: 50 μm. Representative images from 5–6 
animals in each group. (B) The time course of IK17-EGFP and TT-EGFP binding. Transgenic zebrafish larvae were fed a HCD or control diet for 
the indicated number of days. Two days before imaging, fish were subjected to heat shock, and the diet was switched to a diet supplemented 
with cholesteryl BODIPY 576/589. Different groups of larvae were used for each time point. The results are expressed as the percentage of the 
area of EGFP signal normalized to the area of the caudal vein segment. Mean ± SEM (5–15 animals in each group at each time point).*P < 0.05; 
**P < 0.01. (C) One group of larvae was fed a HCD for 10 days, and the other group was fed a HCD for 5 days, followed by control diet for next 
5 days. Mean ± SEM (13–18 animals in each group at each time point). **P < 0.01.
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IK17 expression inhibits vascular lipid accumulation. 


































Effect of probucol on vascular lipid accumulation and 
IK17-EGFP binding in HCD-fed transgenic larvae. 
hsp70:IK17-EGFP zebrafish larvae were fed control 
diet, HCD, or HCD supplemented with 0.05% probucol. 
Other conditions were as in Figure 3. (A) Images of vas-
cular lipid deposits and IK17-EGFP binding after 5 days 
of feeding. Dashed lines trace the caudal vein in GFP-
only images. Scale bar: 25 μm. (B) Area of lipid depos-
its normalized to the area of the caudal vein segment. 
(C) IK17-EGFP binding expressed as the percentage of 
the area of EGFP signal normalized to the area of the 
caudal vein segment. Mean ± SEM (10–23 animals in 
each group at each time point). *P < 0.05. **P < 0.01.
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Zebrafish homogenates expressing IK17-EGFP inhib-
it MDA-LDL binding to macrophages. (A) In a macro-
phage binding experiment, binding of 0.15 μg/ml 
MDA-LDL to J774 cells was inhibited by indicated 
concentrations of IK17-scFv or TT-scFv. Two inde-
pendent experiments were performed in triplicate. (B) 
The homogenates of hsp70:IK17-EGFP and hsp70:
TT-EGFP zebrafish larvae (pooled from 50 animals 
in each group) that were used in the experiment 
shown in Figure 2E and at concentrations indicated 
were used to inhibit binding of 0.15 μg/ml MDA-LDL 
to J774 cells. Graphs are representative of 2 indepen-
dent experiments, performed in triplicate.
Figure 6
Expression of IK17-EGFP attenuates vascular lipid accumulation. (A) hsp70:IK17-EGFP 
and hsp70:TT-EGFP zebrafish larvae were fed a HCD or control diet for 10 days. One group 
of HCD-fed zebrafish was subjected to heat shock 2 days before the start of feeding and 
then every 4–5 days to sustain IK17-EGFP or TT-EGFP expression levels. The other group 
was not subjected to heat shock at any time and, thus, did not express the transgene. Two 
days before imaging, the diet was switched to a diet supplemented with 10 μg/g cholesteryl 
BODIPY 576/589 C11, and then fluorescent lipid deposits were quantified. The results are 
expressed as the percentage of the area of lipid deposits normalized to the area of the cau-
dal vein segment. Mean ± SEM (21–34 animals in each hsp70:IK17-EGFP zebrafish group 
and 10–19 animals in each hsp70:TT-EGFP group). *P < 0.001 for IK17/HCD versus either 
IK17/control or IK17/HCD/heat shock. (B) Zebrafish larvae were fed a HCD for 5 days, and 
lipid deposits were imaged and quantified. The animals were subjected to heat shock after 
the imaging session on the fifth day and then again on the eighth day. The animals were 
imaged again on the tenth day, and lipid deposits were quantified. The results are expressed 
as the percentage area of lipid deposits per caudal vein segment. Mean ± SEM (12–21 ani-
mals in each group at each time point). *P < 0.05.
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